II. Indications
III. Mechanism
- Neprilysin Inhibitors (e.g. Sacubitril)
- Blocks neprilysin activity and its breakdown of natriuretic peptides
- Resulting prolonged natriuretic peptide activity increases vasodilation and Sodium excretion
- Sacubitril
- Prodrug that is metabolized to its active form
- Typical Neprilysin Inhibitor use is in combination with Angiotensin Receptor Blocker (e.g. Entresto)
- Adding an ARB, prevents compensatory Angiotensin activation in response to Sacubitril
IV. Dosing
V. Adverse Effects
- Combined with Valsartan (Entresto)
- Risk of Hypotension (Number needed to harm 21)
- Risk of Angioedema (Number needed to harm 200)
VI. Drug Interactions
- Combined with Valsartan (Entresto)
VII. References
- (2015) Presc Lett 22(9): 49
- McMurray (2014) N Engl J Med 371(11):993-1004 +PMID:25176015 [PubMed]
Images: Related links to external sites (from Bing)
Related Studies
entresto (on 7/27/2022 at Medicaid.Gov Survey of pharmacy drug pricing) | ||
ENTRESTO 24 MG-26 MG TABLET | $10.18 each | |
ENTRESTO 49 MG-51 MG TABLET | $10.18 each | |
ENTRESTO 97 MG-103 MG TABLET | $10.18 each |